港股異動丨輝煌明天(1351.HK)大漲逾21% 股價創上市新高
格隆匯12月23日丨輝煌明天科技控股(1351.HK)尾盤漲幅擴大至21.15%,高見1.95港元創上市新高價,上市一個半月累計漲幅達71%。暫成交3246萬港元,總市值9.45億港元。公司是一家移動廣告公司,為客户提供一站式定製廣告服務。2020年前四個月,公司的利潤增速高於收入增長反映出公司的盈利能力在強化。根據其招股書表述,公司2019年按每次銷售成本收費的精準服務每1元平均利潤的大幅增長,主要歸因於一名新客户的廣告訂單。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.